It’s no secret that the cannabis industry has faced some challenges since legalization. Though regulations are changing in favour of the industry’s growth, residue from past taboos and fumbled launches continue to wreak havoc on potential profits. Add to this the complications of some challenging times for markets in the wake of COVID-19 and ...
As we’ve spoken about in previous blog posts, the psychedelics industry has been rapidly expanding to become a key component in the treatment of a host of mental illnesses. With multiple parties progressing promising research studies, industry players going public, and regulations across the world relaxing for the industry, the future is looking brighter ...
Innovations in psychedelics are poised to disrupt the pharmaceutical industry, and the Zeifmans Cannabis and Psychedelics Team has been hard at work in the space and is here to demystify these interesting developments. We’re proud to announce our entry into podcasting, having recently launched a brand-new endeavor: “Micro-dosing with Zeifmans”. To listen, look us ...
Research is proving the impressive efficacy of psychedelics in treating conditions like anxiety, depression, and opioid addiction. Psychedelic substances like MDMA, LSD, ketamine, and most notably psilocybin (magic mushrooms) have been gaining traction in recent years as several clinical trials enter Phase II and beyond. And as the cannabis industry has experienced some undeniable ...
If you feel like your understanding of the Canadian cannabis market changes with the wind, you’re not alone. One year after cannabis was legalized in Canada, the regulations have changed a number of times. Particularly in Ontario, the retail strategy seems to be a moving target for producers, who are now facing an issue ...
Some might argue that the marijuana leaf is to Jamaica what the maple leaf is to Canada. Through centuries of history, cannabis has been woven into Jamaican culture. And since the plant was legalized for medical use in 2015, many Jamaican companies have been eagerly awaiting the opportunity to grow the business sector, including ...
The Canadian cannabis industry has arrived at an impressive level of financial success following a sometimes rocky road to recreational legalization. In just a handful of years, we’ve seen the use of cannabis go from social taboo to widely accepted, and the cultivation and sale of the plant go from shady criminal pastime to ...
Last year’s full legalization of cannabis in Canada opened the door for an already growing industry to gain further momentum. But the country’s cannabis producers have experienced challenges as the government continues to evolve the licensing process. Health Canada has stated the intention of encouraging both large and small cannabis producers, but many are ...
Legal sales of cannabis in Canada are expected to reach $6.5 billion per annum by 2020. As this industry reaches new heights, there is ample opportunity for both entrepreneurs, investors and already existing cannabis businesses in the space to grow in this exciting market. Let Zeifmans help you navigate through the weeds. To learn more, ...
After several years of deliberation, last month Israel approved the export of medical cannabis cultivated within its borders. The Israeli Knesset unanimously gave the green light to the law[1], which further positions the Israeli medical cannabis market as a major player in the global industry. The government is projecting exports of $265 million per ...